
New chief financial officer for Shire
pharmafile | May 12, 2015 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Shire, jeff poulton
Irish pharma firm Shire has appointed a new chief financial officer and member of its executive committee in Jeff Poulton.
Poulton has served as interim CFO since December last year while overseeing investor relations for the Dublin-based company. As CFO he will remain based in Lexington in the US.
Poulton joined Shire in 2003 and has extensive experience across financial, commercial and strategic leadership roles. His experience at the firm includes leading its rare diseases unit, and overseeing the integration of Viropharma’s products into Shire’s portfolio.
Shire chief executive Flemming Ornskov says: “Jeff brings demonstrated leadership capabilities across all elements of the finance organisation as well as deep knowledge of the Shire business and effective relationships with the investment community and other stakeholders.”
Shire chairman Susan Kilsby adds: “Jeff will join the Shire board of directors at a time when the company is building for the future. We have conducted an extensive search of both internal and external candidates. Jeff’s expertise and extensive knowledge of Shire’s business and markets set him apart as CFO and will further strengthen the Shire board as it oversees the company’s transformation.”
Related Content

Takeda plans to vacate all 1,000 staff from US HQ by the year’s end
Takeda has announced its plans to vacate all staff from its US headquarters in Deerfield, …

Novartis buys dry eye treatment Xiidra in deal worth $5.3 billion
Japanese multinational Takeda Pharmaceutical has agreed to sell its dry eye drug Xiidra to Swiss …

Top Ten most popular articles on Pharmafile.com this week!
With the completion of Takeda’s £46 billion acquisition of Shire finally done, another even bigger …






